01-11-2019
Bill Perry / Shutterstock.com
The US Court of Appeals for the Federal Circuit yesterday, October 31 ruled that the appointment and oversight of the US Patent and Trademark Office (USPTO) patent review judges was unconstitutional, and expanded the powers of the office’s director to resolve the problem.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
Patent Trial and Appeal Board, PTAB, US Patent and Trademark Office, US Court of Appeals for the Federal Circuit, APJ, USPTO
Chevron heads off Arthrex challenge at Fed Circuit
22-01-2021
Lawyers keenly-awaiting Arthrex showdown
14-10-2020
USPTO urges Fed Circuit to wait for SCOTUS on Arthrex
13-08-2020
IPR prompts US govt to double down on Arthrex rerun
08-01-2020
US government urges Fed Circuit to rethink landmark Arthrex ruling
18-12-2019
SCOTUS urged to reject IPR immunity appeal after Arthrex
09-12-2019
PTAB urges law firms to include more women on trial teams
18-11-2019
